Foresight Diagnostics: Sandra Close

Foresight Diagnostics has hired Sandra Close as its chief operations officer. She was previously chief diagnostic strategy officer at ArcherDx and then Invitae after it acquired ArcherDx, where she led work to develop a next-generation sequencing-based molecular diagnostic platform to detect genetic mutations, including minimal residual disease products. Before that, she was chief of integrative science and collaborative research at BioStatistics Solutions, chief scientific officer at Arrogen, and a research advisor at Eli Lilly.